Lonza Group Reports Q3 Performance In Line With Expectations; Backs Annual Outlook

8 hours ago

(AWP Alliance News) - Lonza Group (LZAGF.PK, LONN.SW), a Swiss manufacturing company for the pharmaceutical, biotechnology, and nutrition industries, said on Wednesday that its financial performance was in line with expectations across all of its business platforms for the third quarter.

Wolfgang Wienand, CEO of Lonza, said: "Lonza performed well in Q3 2026 and we continued to successfully execute our One Lonza Strategy. The transformation into a pure-play CDMO has created a stronger, more integrated global organization that is delivering for our customers across all business platforms."

For fiscal 2026, the Group still expects 11% to 12% CER sales growth with Core EBITDA margin of 33% to 34%. Lonza continues to anticipate a negative foreign exchange impact of around 2% to 3% on 2026 sales growth.

Learn more about our offers

Keep a close eye on your favourite shares

Watchlist

Don’t miss out on share price trends. Track your favourite shares (CH, EU & US) in real time with customised watchlists.

Sign up now Opens a dialog window.
Compare ETFs systematically

ETF Compass

Find the products that suit your investment goals.

Try the ETF Compass
How to find the best shares

theScreener

Search through around 6,500 securities using criteria such as opportunities and risks or expected dividend yield.

Test now Opens a dialog window.

Lonza Group Reports Q3 Performance In Line With Expectations; Backs Annual Outlook

Description

Learn more about our offers

Keep a close eye on your favourite shares

Compare ETFs systematically

How to find the best shares